Overexpression of cancer-associated short glycan (sugar chains) structures (green) on proteins in cancer cells. (Kirstine Lavrsen)
A new screening tool developed by scientists in Denmark, comprising a microarray system that analyzes patients’ blood, could detect the presence of autoantibodies as a warning sign of cancer.